Viewing Study NCT00035360


Ignite Creation Date: 2025-12-25 @ 2:17 AM
Ignite Modification Date: 2025-12-27 @ 12:08 PM
Study NCT ID: NCT00035360
Status: COMPLETED
Last Update Posted: 2017-03-10
First Post: 2002-05-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase III PEG-Intron in HIV-infected Patients (Study P00738)
Sponsor: Merck Sharp & Dohme LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module References Module